本页面由Tiger Trade Technology Pte. Ltd.提供服务

Evolent Health Inc

3.02
-0.0050-0.17%
成交量:24.49万
成交额:75.08万
市值:3.36亿
市盈率:-0.59
高:3.12
开:3.04
低:3.02
收:3.02
52周最高:12.07
52周最低:2.50
股本:1.12亿
流通股本:8,693.99万
量比:0.68
换手率:0.28%
股息:- -
股息率:- -
每股收益(TTM):-5.0732
每股收益(LYR):-5.0732
净资产收益率:-66.54%
总资产收益率:-0.12%
市净率:0.81
市盈率(LYR):-0.59

数据加载中...

公司资料

公司名字:
Evolent Health Inc
交易所:
NYSE
成立时间:
2011
员工人数:
4200
公司地址:
1812 N. Moore Street,Suite 1705,Arlington,Virginia,United States
邮编:
22209
电话:
传真:
- -
简介:
Evolent Health, Inc.于2014年12月12日在特拉华州成立。公司致力于为患有癌症、心血管疾病和肌肉骨骼疾病等复杂病症的患者提供整合式医疗服务。公司与健康保险计划和其他风险承担实体合作,支持医疗服务提供者为患者提供高质量的循证医疗服务。Evolent强调遵循临床路径的重要性,以改善患者预后、提升医生体验并降低整体医疗成本。

董事

名称
职位
Seth Blackley
Director and Chief Executive Officer
Brendan Springstubb
Independent Director
Craig Barbarosh
Independent Director
Kim Keck
Independent Director
Peter Grua
Independent Director
Richard Jelinek
Independent Director
Russell Glass
Independent Director
Shawn Guertin
Independent Director
Toyin Ajayi
Independent Director
Jill Smith
Director

股东

名称
职位
Seth Blackley
Director and Chief Executive Officer
Katie DiPerna
Chief Operating Officer
Mario Ramos
Chief Financial Officer
Aammaad Shams
Chief Accounting Officer
Dan McCarthy
President
Emily Rafferty
EVP, Customer Success
John Johnson
Chief Strategy Officer
Jonathan Weinberg
General Counsel